Respiratory Diagnostic Market Size, Trends and Insights By Product and Services (Assays and reagents, instruments and devices, Services and software), By Test Type (Mechanical tests, Molecular diagnostic test, OSA diagnostic test, Traditional diagnostic tests, Imaging tests), By Disease (Lung cancer, Tuberculosis, Chronic obstructive pulmonary disorder, Bronchitis, Pulmonary fibrosis, Asthma, Other diseases), By End User (Physician offices, Hospital, Clinical laboratories, Others), By Distribution Channel (Retail sales, Direct tender, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Medtronic (Ireland)
- COSMED srl (Italy)
- GENERAL ELECTRIC COMPANY (US)
- Others
Reports Description
According to Custom Market Insights (CMI), The Global Respiratory Diagnostics Market Size was valued at USD 8.2 billion in 2021 and is expected to reach USD 9.1 billion in 2022 is estimated to reach USD 13.80 billion by the end of 2030 at a CAGR of approximately 8.5% during the forecast period 2022-2030.
The increasing prevalence of respiratory disorders has boosted the market demand for advanced respiratory diagnostic facilities. In addition, the rapidly increasing number of people in the geriatric age group has also increased the demand for advanced respiratory agnostic facilities.
The high cost associated with the diagnostic procedures and imaging techniques to diagnose a particular respiratory condition hampers the market’s growth tremendously. In addition, a lack of awareness among the people regarding advanced medical facilities and diagnostic procedures has dramatically hindered the market’s growth. Furthermore, the rapidly increasing environmental pollution has also boosted the market’s number of patients suffering from respiratory disorders.
The pandemic outbreak significantly impacted the respiratory diagnostics market, and the respiratory system was the primary target during this season. The increasing demand for diagnostic techniques to evaluate the respiratory condition of an individual hard boosted the market for respiratory diagnostic systems. Every respiratory disorder and Disease was observed closely, and repeated tests were conducted to evaluate the condition accurately so that the patients suffering from COVID were treated separately. In addition, the hospitals avoided regular follow-ups of the patient to avoid the chances of cross-infection.
Growth Factors
The extensive research and development programs carried out by the key market players to introduce advanced diagnostic procedures to produce faster results with accuracy have boosted the economy for respiratory diagnostic systems. In addition, the key market players’ considerable investment in advanced techniques and diagnostic procedures has also attracted potential consumers to take advantage of these facilities.
Lucrative offers provided by the healthcare industry through insurance companies in the form of reimbursement facilities have also contributed significantly to the growth of the respiratory diagnostics market. Furthermore, the increasing prevalence of respiratory disorders among people due to faulty lifestyle practices, which include the consumption of tobacco and smoking, has boosted the economy for respiratory diagnostic procedures. In addition, the pandemic outbreak has made people more cautious about their respiratory health, which has emerged as a significant driving force for the market’s growth.
The large number of people belonging to the geriatric population has boosted the demand for advanced diagnostic procedures for respiratory diseases to carry out suitable treatment well in advance. In addition, the availability of high disposable income with the people enables them to opt for advanced respiratory diagnostic procedures. These reasons have helped the market to grow and achieve new heights.
Segmental Insights
Segmentation of the respiratory diagnostics market based on Product and Services
Based on products and services, the segment of instruments and devices has significantly contributed to the market’s growth and covers the most significant share due to its extensive demand in the current market. In addition, the rapid increase in the number of diagnostic tests being carried out worldwide to a particular line of treatment that needs to be followed for a faster recovery demands the use of modern equipment and devices by the healthcare industry.
The key market players are conducting constant research and development regarding the advancement of technology and devices to make the tests more accurate and precise. Advanced technology has reduced the time required to complete a particular test type. Reagents and assays from the next segment show tremendous growth in the current market due to their extensive use in laboratories for conducting blood tests for diagnostic purposes. Even basic blood tests require reagents to obtain the desired result in a shorter time. In addition, laboratories have extensively used software and services to automate their services and increase test speed by evaluating them using artificial intelligence.
The healthcare system is adopting advanced software to manage vast amounts of data and process them in a shorter time. As a result, key market players are developing new software and services to attract potential consumers by providing accurate results in a shorter time.
Segmentation of the respiratory diagnostics market based on Test Type
Based on test type, OSA diagnostic test has emerged as the largest segment due to its extensive use in laboratories. The quicker results obtained with the help of this technology have made it an option of choice for laboratories worldwide. In addition, rapid modernization has demanded faster results over a shorter time with accuracy, which has boosted the need for OSA diagnostic tests.
The mechanical test has emerged as the next largest segment due to its massive demand in the healthcare sector. The next segment discussed under this category is imaging tests that I use mainly in hospitals and scan centres for performing advanced studies regarding the pathological changes that have occurred in the body and lead to abnormalities. The diagnostic test is the next segment under this category that has emerged as a new market for the healthcare system, showing considerable growth with the increasing demand for advanced technologies and techniques in the diagnostic field.
Segmentation of the respiratory diagnostics market based on Disease
Based on Disease, lung cancer has emerged as the fastest-growing market due to its high prevalence worldwide, but the tuberculosis segment has dominated this category with its massive contribution in terms of revenue. In addition, various habitual practices such as smoking and consuming tobacco have boosted the chances of tuberculosis among the people, which has, in turn, propelled the growth of the market tremendously.
The rapidly increasing pollution worldwide has also boosted the number of respiratory diseases in society. This gives rise to several advanced tests being carried out on people to rule out many conditions. In addition, the high prevalence of lung cancer among people also needs advanced diagnostic procedures, propelling the size of the respiratory diagnostics market.
The vast number of people in the geriatric age group has also contributed sufficiently due to the prevalence of respiratory diseases. The other conditions included under this category are asthma and chronic obstructive pulmonary disorder, which are very common worldwide and require better diagnostic facilities to facilitate cures in a shorter time.
Segmentation of the respiratory diagnostics market based on Distribution Channel
Based on the distribution channel, tremendous growth has been observed in the retail sector due to the enormous demand for advanced diagnostic facilities to obtain accurate results over a shorter time. As a result, the retail sector has provided a wide variety of services to the healthcare industry to facilitate respiratory diagnostic procedures. On the other hand, the direct tender segment is showing faster growth due to the cost-effective nature of its diagnostic procedures.
Segmentation of the respiratory diagnostics market based on End Users
Based on end-user, clinical laboratories have presented the largest market share due to the rising demand for respiratory diagnostic facilities in the healthcare sector. As most patients with respiratory diseases present themselves in a hospital, the growth of the clinical laboratories segment has emerged as the fastest among all the other competitors. The advanced facilities in this sector under a single roof enable the patient to easily take advantage of the required services. In addition, the pandemic outbreak enabled many hospitals and clinics to possess multiple advanced technologies to provide the best service to consumers.
Report Scope
| Feature of the Report | Details |
| Market Size in 2021 | USD 8.2 Billion |
| Projected Market Size in 2030 | USD 13.80 Billion |
| CAGR Growth Rate | 8.5% CAGR (2022-2030) |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Prominent Players | Medtronic (Ireland), COSMED srl (Italy) , GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), NIHON KOHDEN CORPORATION (Japan), GC Diagnostics Corporation (South Korea), Masimo (US), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (US), bioMérieux SA (France), Carestream Health (US), Abbott (US), Johnson & Johnson Services Inc. (US), Thermo Fisher Scientific Inc. (US), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Bayer AG (Germany), BD (US), and Others |
| Key Segment | By Product and Services, By Test Type, By Disease, By End User, By Distribution Channel, and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Regional Insights
Based on geography, the region of North America has emerged as the fastest-growing market for respiratory diagnostics due to the high prevalence of chronic respiratory diseases in this region. In addition, the vast number of people belonging to the geriatric population has boosted the demand for advanced respiratory diagnostics services in the market. Furthermore, the rapid climate change and increasing pollution owing to the fast development that is taking place have emerged to be a significant driving factor for the respiratory diagnostics market.
That one stealth care facility provided by the government to attract potential consumers in the form of reimbursement facilities by insurance companies has boosted the demand for respiratory diagnostics systems in the market. The European nations emerge as the second largest market for respiratory diagnostics due to the increasing prevalence of respiratory disorders. Advanced facilities provided by this region’s healthcare system have boosted the respiratory diagnostics market.
Key Players
- Medtronic (Ireland)
- COSMED srl (Italy)
- GENERAL ELECTRIC COMPANY (US)
- Koninklijke Philips N.V. (Netherlands)
- Hoffmann-La Roche Ltd (Switzerland)
- NIHON KOHDEN CORPORATION (Japan)
- GC Diagnostics Corporation (South Korea)
- Masimo (US)
- Drägerwerk AG & Co. KGaA (Germany)
- Bio-Rad Laboratories Inc. (US)
- bioMérieux SA (France)
- Carestream Health (US)
- Abbott (US)
- Johnson & Johnson Services Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Novartis AG (Switzerland)
- GlaxoSmithKline plc (UK)
- Bayer AG (Germany)
- BD (US)
Recent developments
- In May 2020 – a collaboration was made between SIME and an existing investor to expand the business.
- In June 2020 – thoracic care suit was introduced by GE Healthcare, including artificial intelligence algorithms. The 8 algorithms present in this system assist in diagnosing the abnormalities in the chest X-ray.
- In July 2020 – three diagnostic kits into the market by BATM. The company took this step to enhance the diagnostic facilities for covid.
Segments covered in the report
By Product and Services
- Assays and reagents
- instruments and devices
- Services and software
By Test Type
- Mechanical tests
- Molecular diagnostic test
- OSA diagnostic test
- Traditional diagnostic tests
- Imaging tests
By Disease
- Lung cancer
- Tuberculosis
- Chronic obstructive pulmonary disorder
- Bronchitis
- Pulmonary fibrosis
- Asthma
- Other diseases
By End User
- Physician offices
- Hospital
- Clinical laboratories
- Others
By Distribution Channel
- Retail sales
- Direct tender
- Others
On the basis of Geography
North America
- The U.S.
- Canada
- Mexico
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Respiratory Diagnostics Market, (2022 – 2030) (USD Billion)
- 2.2 Global Respiratory Diagnostics Market : snapshot
- Chapter 3. Global Respiratory Diagnostics Market – Industry Analysis
- 3.1 Respiratory Diagnostics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 The Extensive Research And Development
- 3.2.2 Faulty Lifestyle Practices
- 3.2.3 The Consumption Of Tobacco And Smoking
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product and Services
- 3.7.2 Market attractiveness analysis By Test Type
- 3.7.3 Market attractiveness analysis By Disease
- 3.7.4 Market attractiveness analysis By End User
- 3.7.5 Market attractiveness analysis By Distribution
- Chapter 4. Global Respiratory Diagnostics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Respiratory Diagnostics Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Respiratory Diagnostics Market – Product and Services Analysis
- 5.1 Global Respiratory Diagnostics Market overview: By Product and Services
- 5.1.1 Global Respiratory Diagnostics Market share, By Product and Services, 2021 and 2030
- 5.2 Assays and reagents
- 5.2.1 Global Respiratory Diagnostics Market by Assays and reagents, 2022 – 2030 (USD Billion)
- 5.3 instruments and devices
- 5.3.1 Global Respiratory Diagnostics Market by instruments and devices, 2022 – 2030 (USD Billion)
- 5.4 Services and software
- 5.4.1 Global Respiratory Diagnostics Market by Services and software, 2022 – 2030 (USD Billion)
- 5.1 Global Respiratory Diagnostics Market overview: By Product and Services
- Chapter 6. Global Respiratory Diagnostics Market – Test Type Analysis
- 6.1 Global Respiratory Diagnostics Market overview: By Test Type
- 6.1.1 Global Respiratory Diagnostics Market share, By Test Type, 2021 and 2030
- 6.2 Mechanical tests
- 6.2.1 Global Respiratory Diagnostics Market by Mechanical tests, 2022 – 2030 (USD Billion)
- 6.3 Molecular diagnostic test
- 6.3.1 Global Respiratory Diagnostics Market by Molecular diagnostic test, 2022 – 2030 (USD Billion)
- 6.4 OSA diagnostic test
- 6.4.1 Global Respiratory Diagnostics Market by OSA diagnostic test, 2022 – 2030 (USD Billion)
- 6.5 Traditional diagnostic tests
- 6.5.1 Global Respiratory Diagnostics Market by Traditional diagnostic tests, 2022 – 2030 (USD Billion)
- 6.6 Imaging tests
- 6.6.1 Global Respiratory Diagnostics Market by Imaging tests, 2022 – 2030 (USD Billion)
- 6.1 Global Respiratory Diagnostics Market overview: By Test Type
- Chapter 7. Global Respiratory Diagnostics Market – Disease Analysis
- 7.1 Global Respiratory Diagnostics Market overview: By Disease
- 7.1.1 Global Respiratory Diagnostics Market share, By Disease, 2021 and 2030
- 7.2 Lung cancer
- 7.2.1 Global Respiratory Diagnostics Market by Lung cancer, 2022 – 2030 (USD Billion)
- 7.3 Tuberculosis
- 7.3.1 Global Respiratory Diagnostics Market by Tuberculosis, 2022 – 2030 (USD Billion)
- 7.4 Chronic obstructive pulmonary disorder
- 7.4.1 Global Respiratory Diagnostics Market by Chronic obstructive pulmonary disorder, 2022 – 2030 (USD Billion)
- 7.5 Bronchitis
- 7.5.1 Global Respiratory Diagnostics Market by Bronchitis, 2022 – 2030 (USD Billion)
- 7.6 Pulmonary fibrosis
- 7.6.1 Global Respiratory Diagnostics Market by Pulmonary fibrosis, 2022 – 2030 (USD Billion)
- 7.7 Asthma
- 7.7.1 Global Respiratory Diagnostics Market by Asthma, 2022 – 2030 (USD Billion)
- 7.8 Other diseases
- 7.8.1 Global Respiratory Diagnostics Market by Other diseases, 2022 – 2030 (USD Billion)
- 7.1 Global Respiratory Diagnostics Market overview: By Disease
- Chapter 8. Global Respiratory Diagnostics Market – End User Analysis
- 8.1 Global Respiratory Diagnostics Market overview: By End User
- 8.1.1 Global Respiratory Diagnostics Market share, By End User, 2021 and 2030
- 8.2 Physician offices
- 8.2.1 Global Respiratory Diagnostics Market by Physician offices, 2022 – 2030 (USD Billion)
- 8.3 Hospital
- 8.3.1 Global Respiratory Diagnostics Market by Hospital, 2022 – 2030 (USD Billion)
- 8.4 Clinical laboratories
- 8.4.1 Global Respiratory Diagnostics Market by Clinical laboratories, 2022 – 2030 (USD Billion)
- 8.1 Global Respiratory Diagnostics Market overview: By End User
- Chapter 9. Global Respiratory Diagnostics Market – Distribution Analysis
- 9.1 Global Respiratory Diagnostics Market overview: By Distribution
- 9.1.1 Global Respiratory Diagnostics Market share, By Distribution, 2021 and 2030
- 9.2 Retail sales
- 9.2.1 Global Respiratory Diagnostics Market by Retail sales, 2022 – 2030 (USD Billion)
- 9.3 Direct tender
- 9.3.1 Global Respiratory Diagnostics Market by Direct tender, 2022 – 2030 (USD Billion)
- 9.1 Global Respiratory Diagnostics Market overview: By Distribution
- Chapter 10. Respiratory Diagnostics Market – Regional Analysis
- 10.1 Global Respiratory Diagnostics Market Regional Overview
- 10.2 Global Respiratory Diagnostics Market Share, by Region, 2021 & 2030 (USD Billion)
- 10.3. North America
- 10.3.1 North America Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.3.1.1 North America Respiratory Diagnostics Market, by Country, 2022 – 2030 (USD Billion)
- 10.3.1 North America Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.4 North America Respiratory Diagnostics Market, by Product and Services, 2022 – 2030
- 10.4.1 North America Respiratory Diagnostics Market, by Product and Services, 2022 – 2030 (USD Billion)
- 10.5 North America Respiratory Diagnostics Market, by Test Type, 2022 – 2030
- 10.5.1 North America Respiratory Diagnostics Market, by Test Type, 2022 – 2030 (USD Billion)
- 10.6 North America Respiratory Diagnostics Market, by Disease, 2022 – 2030
- 10.6.1 North America Respiratory Diagnostics Market, by Disease, 2022 – 2030 (USD Billion)
- 10.7 North America Respiratory Diagnostics Market, by End User, 2022 – 2030
- 10.7.1 North America Respiratory Diagnostics Market, by End User, 2022 – 2030 (USD Billion)
- 10.8 North America Respiratory Diagnostics Market, by Distribution, 2022 – 2030
- 10.8.1 North America Respiratory Diagnostics Market, by Distribution, 2022 – 2030 (USD Billion)
- 10.9. Europe
- 10.9.1 Europe Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.9.1.1 Europe Respiratory Diagnostics Market, by Country, 2022 – 2030 (USD Billion)
- 10.9.1 Europe Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.10 Europe Respiratory Diagnostics Market, by Product and Services, 2022 – 2030
- 10.10.1 Europe Respiratory Diagnostics Market, by Product and Services, 2022 – 2030 (USD Billion)
- 10.11 Europe Respiratory Diagnostics Market, by Test Type, 2022 – 2030
- 10.11.1 Europe Respiratory Diagnostics Market, by Test Type, 2022 – 2030 (USD Billion)
- 10.12 Europe Respiratory Diagnostics Market, by Disease, 2022 – 2030
- 10.12.1 Europe Respiratory Diagnostics Market, by Disease, 2022 – 2030 (USD Billion)
- 10.13 Europe Respiratory Diagnostics Market, by End User, 2022 – 2030
- 10.13.1 Europe Respiratory Diagnostics Market, by End User, 2022 – 2030 (USD Billion)
- 10.14 Europe Respiratory Diagnostics Market, by Distribution, 2022 – 2030
- 10.14.1 Europe Respiratory Diagnostics Market, by Distribution, 2022 – 2030 (USD Billion)
- 10.15. Asia Pacific
- 10.15.1 Asia Pacific Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.15.1.1 Asia Pacific Respiratory Diagnostics Market, by Country, 2022 – 2030 (USD Billion)
- 10.15.1 Asia Pacific Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.16 Asia Pacific Respiratory Diagnostics Market, by Product and Services, 2022 – 2030
- 10.16.1 Asia Pacific Respiratory Diagnostics Market, by Product and Services, 2022 – 2030 (USD Billion)
- 10.17 Asia Pacific Respiratory Diagnostics Market, by Test Type, 2022 – 2030
- 10.17.1 Asia Pacific Respiratory Diagnostics Market, by Test Type, 2022 – 2030 (USD Billion)
- 10.18 Asia Pacific Respiratory Diagnostics Market, by Disease, 2022 – 2030
- 10.18.1 Asia Pacific Respiratory Diagnostics Market, by Disease, 2022 – 2030 (USD Billion)
- 10.19 Asia Pacific Respiratory Diagnostics Market, by End User, 2022 – 2030
- 10.19.1 Asia Pacific Respiratory Diagnostics Market, by End User, 2022 – 2030 (USD Billion)
- 10.20 Asia Pacific Respiratory Diagnostics Market, by Distribution, 2022 – 2030
- 10.20.1 Asia Pacific Respiratory Diagnostics Market, by Distribution, 2022 – 2030 (USD Billion)
- 10.21. Latin America
- 10.21.1 Latin America Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.21.1.1 Latin America Respiratory Diagnostics Market, by Country, 2022 – 2030 (USD Billion)
- 10.21.1 Latin America Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.22 Latin America Respiratory Diagnostics Market, by Product and Services, 2022 – 2030
- 10.22.1 Latin America Respiratory Diagnostics Market, by Product and Services, 2022 – 2030 (USD Billion)
- 10.23 Latin America Respiratory Diagnostics Market, by Test Type, 2022 – 2030
- 10.23.1 Latin America Respiratory Diagnostics Market, by Test Type, 2022 – 2030 (USD Billion)
- 10.24 Latin America Respiratory Diagnostics Market, by Disease, 2022 – 2030
- 10.24.1 Latin America Respiratory Diagnostics Market, by Disease, 2022 – 2030 (USD Billion)
- 10.25 Latin America Respiratory Diagnostics Market, by End User, 2022 – 2030
- 10.25.1 Latin America Respiratory Diagnostics Market, by End User, 2022 – 2030 (USD Billion)
- 10.26 Latin America Respiratory Diagnostics Market, by Distribution, 2022 – 2030
- 10.26.1 Latin America Respiratory Diagnostics Market, by Distribution, 2022 – 2030 (USD Billion)
- 10.27. The Middle-East and Africa
- 10.27.1 The Middle-East and Africa Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.27.1.1 The Middle-East and Africa Respiratory Diagnostics Market, by Country, 2022 – 2030 (USD Billion)
- 10.27.1 The Middle-East and Africa Respiratory Diagnostics Market, 2022 – 2030 (USD Billion)
- 10.28 The Middle-East and Africa Respiratory Diagnostics Market, by Product and Services, 2022 – 2030
- 10.28.1 The Middle-East and Africa Respiratory Diagnostics Market, by Product and Services, 2022 – 2030 (USD Billion)
- 10.29 The Middle-East and Africa Respiratory Diagnostics Market, by Test Type, 2022 – 2030
- 10.29.1 The Middle-East and Africa Respiratory Diagnostics Market, by Test Type, 2022 – 2030 (USD Billion)
- 10.30 The Middle-East and Africa Respiratory Diagnostics Market, by Disease, 2022 – 2030
- 10.30.1 The Middle-East and Africa Respiratory Diagnostics Market, by Disease, 2022 – 2030 (USD Billion)
- 10.31 The Middle-East and Africa Respiratory Diagnostics Market, by End User, 2022 – 2030
- 10.31.1 The Middle-East and Africa Respiratory Diagnostics Market, by End User, 2022 – 2030 (USD Billion)
- 10.32 The Middle-East and Africa Respiratory Diagnostics Market, by Distribution, 2022 – 2030
- 10.32.1 The Middle-East and Africa Respiratory Diagnostics Market, by Distribution, 2022 – 2030 (USD Billion)
- Chapter 11. Company Profiles
- 11.1 Medtronic (Ireland)
- 11.1.1 Overview
- 11.1.2 Financials
- 11.1.3 Product Portfolio
- 11.1.4 Business Strategy
- 11.1.5 Recent Developments
- 11.2 COSMED srl (Italy)
- 11.2.1 Overview
- 11.2.2 Financials
- 11.2.3 Product Portfolio
- 11.2.4 Business Strategy
- 11.2.5 Recent Developments
- 11.3 GENERAL ELECTRIC COMPANY (US)
- 11.3.1 Overview
- 11.3.2 Financials
- 11.3.3 Product Portfolio
- 11.3.4 Business Strategy
- 11.3.5 Recent Developments
- 11.4 Koninklijke Philips N.V. (Netherlands)
- 11.4.1 Overview
- 11.4.2 Financials
- 11.4.3 Product Portfolio
- 11.4.4 Business Strategy
- 11.4.5 Recent Developments
- 11.5 F. Hoffmann-La Roche Ltd (Switzerland)
- 11.5.1 Overview
- 11.5.2 Financials
- 11.5.3 Product Portfolio
- 11.5.4 Business Strategy
- 11.5.5 Recent Developments
- 11.6 NIHON KOHDEN CORPORATION (Japan)
- 11.6.1 Overview
- 11.6.2 Financials
- 11.6.3 Product Portfolio
- 11.6.4 Business Strategy
- 11.6.5 Recent Developments
- 11.7 GC Diagnostics Corporation (South Korea)
- 11.7.1 Overview
- 11.7.2 Financials
- 11.7.3 Product Portfolio
- 11.7.4 Business Strategy
- 11.7.5 Recent Developments
- 11.8 Masimo (US)
- 11.8.1 Overview
- 11.8.2 Financials
- 11.8.3 Product Portfolio
- 11.8.4 Business Strategy
- 11.8.5 Recent Developments
- 11.9 Drägerwerk AG & Co. KGaA (Germany)
- 11.9.1 Overview
- 11.9.2 Financials
- 11.9.3 Product Portfolio
- 11.9.4 Business Strategy
- 11.9.5 Recent Developments
- 11.10 Bio-Rad Laboratories Inc. (US)
- 11.10.1 Overview
- 11.10.2 Financials
- 11.10.3 Product Portfolio
- 11.10.4 Business Strategy
- 11.10.5 Recent Developments
- 11.11 bioMérieux SA (France)
- 11.11.1 Overview
- 11.11.2 Financials
- 11.11.3 Product Portfolio
- 11.11.4 Business Strategy
- 11.11.5 Recent Developments
- 11.12 Carestream Health (US)
- 11.12.1 Overview
- 11.12.2 Financials
- 11.12.3 Product Portfolio
- 11.12.4 Business Strategy
- 11.12.5 Recent Developments
- 11.13 Abbott (US)
- 11.13.1 Overview
- 11.13.2 Financials
- 11.13.3 Product Portfolio
- 11.13.4 Business Strategy
- 11.13.5 Recent Developments
- 11.14 Johnson & Johnson Services Inc. (US)
- 11.14.1 Overview
- 11.14.2 Financials
- 11.14.3 Product Portfolio
- 11.14.4 Business Strategy
- 11.14.5 Recent Developments
- 11.15 Thermo Fisher Scientific Inc. (US)
- 11.15.1 Overview
- 11.15.2 Financials
- 11.15.3 Product Portfolio
- 11.15.4 Business Strategy
- 11.15.5 Recent Developments
- 11.16 Novartis AG (Switzerland)
- 11.16.1 Overview
- 11.16.2 Financials
- 11.16.3 Product Portfolio
- 11.16.4 Business Strategy
- 11.16.5 Recent Developments
- 11.17 GlaxoSmithKline plc (UK)
- 11.17.1 Overview
- 11.17.2 Financials
- 11.17.3 Product Portfolio
- 11.17.4 Business Strategy
- 11.17.5 Recent Developments
- 11.18 Bayer AG (Germany)
- 11.18.1 Overview
- 11.18.2 Financials
- 11.18.3 Product Portfolio
- 11.18.4 Business Strategy
- 11.18.5 Recent Developments
- 11.19 BD (US)
- 11.19.1 Overview
- 11.19.2 Financials
- 11.19.3 Product Portfolio
- 11.19.4 Business Strategy
- 11.19.5 Recent Developments
- 11.1 Medtronic (Ireland)
List Of Figures
Figures No 1 to 40
List Of Tables
Tables No 1 to 127
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Key Players
- Medtronic (Ireland)
- COSMED srl (Italy)
- GENERAL ELECTRIC COMPANY (US)
- Koninklijke Philips N.V. (Netherlands)
- Hoffmann-La Roche Ltd (Switzerland)
- NIHON KOHDEN CORPORATION (Japan)
- GC Diagnostics Corporation (South Korea)
- Masimo (US)
- Drägerwerk AG & Co. KGaA (Germany)
- Bio-Rad Laboratories Inc. (US)
- bioMérieux SA (France)
- Carestream Health (US)
- Abbott (US)
- Johnson & Johnson Services Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Novartis AG (Switzerland)
- GlaxoSmithKline plc (UK)
- Bayer AG (Germany)
- BD (US)
- Others
FAQs
“North America” region will lead the global Respiratory Diagnostic market during the forecast period 2022 to 2030.
Factors such as increasing lung-related diseases and infections and rise in the geriatric population, and technological developments are leading to growth in the market.
The key players operating in the Respiratory Diagnostic market are Medtronic (Ireland), COSMED srl (Italy) , GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), NIHON KOHDEN CORPORATION (Japan), GC Diagnostics Corporation (South Korea), Masimo (US), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (US), bioMérieux SA (France), Carestream Health (US), Abbott (US), Johnson & Johnson Services Inc. (US), Thermo Fisher Scientific Inc. (US), Novartis AG (Switzerland), GlaxoSmithKline plc (UK), Bayer AG (Germany), BD (US).
The global Respiratory Diagnostic market is expanding growth with a CAGR of approximately 8.5% during the forecast period (2022 to 2030).
The global Respiratory Diagnostic market size was valued at USD 8.2 Billion in 2021 and it is projected to reach around USD 13.80 Billion by 2030.